Zhejiang Hisoar Pharmaceutical Co Ltd. Stock Analysis 002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the production of active pharmaceutical ingredients and fine chemicals. The company is headquartered in Taizhou, Zhejiang and currently employs 2,736 full-time employees. The company went IPO on 2006-12-26. The firm is mainly engaged in the pharmaceutical sector and dye sector business. The pharmaceutical sector business involves the research and development, commercial production and sale of specialty API, pharmaceutical intermediates and generic drugs, and provides customized research and development and production services (contract manufacture organization (CMO)/ contract development and manufacturing organization (CDMO)) for global pharmaceutical companies. The dye sector business covers the research and development, production and sale of environmentally friendly reactive dyes, anthraquinone dyes and dye intermediates. The firm distributes its products within the domestic market and to overseas markets.